Creating new proteins to improve chemical reactions
Development of Flavoproteins as Catalysts for Asymmetric Radical Reactions
This study is working on creating special proteins that help make important chemical reactions work better, which could lead to new and improved medicines for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Princeton University NIH-funded |
| Lab location | 1 site (Princeton, UNITED STATES) |
| Project ID | NIH-11058349 on NIH RePORTER |
What this research studies
This research focuses on developing innovative proteins that can act as catalysts to enhance the efficiency and selectivity of important chemical reactions. By evolving these proteins, the team aims to control the outcomes of reactions involving free radical intermediates, which are crucial for synthesizing various compounds. Patients may benefit from advancements in drug development and chemical synthesis that arise from these improved catalytic processes. The project includes designing catalysts that can favor specific reaction products, potentially leading to more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new drugs developed through enhanced chemical synthesis methods.
Not a fit: Patients with conditions that do not require new drug development or chemical synthesis improvements may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted drug development, improving treatment options for patients.
How similar studies have performed: Other research has shown success in using engineered proteins as catalysts, indicating that this approach has potential for significant advancements.
Where this research is happening
Princeton, UNITED STATES
- Princeton University — Princeton, United States (Active)
Researchers
- Principal investigator: Hyster, Todd Kurt — Princeton University
- Study coordinator: Hyster, Todd Kurt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.